Does Red Clover Improve Bone Density?
Red clover (Trifolium pratense) contains isoflavones like genistein and daidzein, which mimic estrogen's effects in the body. These phytoestrogens may support bone health by reducing bone resorption, similar to hormone replacement therapy (HRT), particularly in postmenopausal women where estrogen decline accelerates bone loss.[1][2]
Small clinical trials show mixed but promising results. A 2014 randomized trial of 78 postmenopausal women taking 120 mg red clover isoflavones daily for 12 months found a 2.3% increase in lumbar spine bone mineral density (BMD) compared to placebo, with no change in femoral neck BMD.[3] Another 2007 study reported modest BMD gains in the lumbar spine after two years of supplementation.[4] However, a 2012 meta-analysis of nine trials concluded isoflavones from soy or red clover provide only weak evidence for preventing postmenopausal bone loss, with effects too small for clinical relevance.[5]
How Does It Compare to Standard Treatments?
Red clover's bone benefits appear weaker than bisphosphonates (e.g., alendronate) or denosumab, which increase BMD by 5-8% in the spine over one year.[6] It may serve as a milder alternative for women avoiding HRT due to breast cancer risks, but evidence doesn't support it as a primary treatment.[1]
| Treatment | Spine BMD Gain (1 year) | Evidence Strength |
|-----------|--------------------------|-------------------|
| Red Clover Isoflavones | 1-3% | Moderate, short-term trials[3][5] |
| Alendronate | 5-6% | Strong, large RCTs[6] |
| HRT (estrogen) | 3-5% | Strong, but with risks[2] |
Who Might Benefit Most?
Postmenopausal women with osteopenia are the main group studied, where estrogen-like effects could slow bone turnover.[3][4] No strong data exists for men, premenopausal women, or osteoporosis patients. Those with soy allergies or on blood thinners should avoid it due to potential interactions.[7]
What Are the Potential Risks and Side Effects?
Common side effects include nausea, headache, and rash (affecting <5% in trials).[3] Estrogenic activity raises concerns for hormone-sensitive cancers like breast or endometrial; long-term safety is unclear.[1][5] It may lower hot flash severity but doesn't match HRT efficacy.[2] Always consult a doctor before use, especially with medications.
When Does Evidence Fall Short?
Larger, longer-term trials are needed; most studies last 6-24 months and use varying doses (40-120 mg isoflavones).[5] Results conflict on hip BMD, and benefits may not reduce fracture risk.[4] Regulatory bodies like the FDA classify red clover as a supplement, not a drug, with no approved bone health claims.[7]
Sources
[1] National Institutes of Health - Red Clover
[2] Mayo Clinic - Phytoestrogens and Menopause
[3] Journal of Nutrition - Red Clover BMD Trial (2014)
[4] Osteoporosis International - 2-Year Study (2007)
[5] Bone - Isoflavones Meta-Analysis (2012)
[6] New England Journal of Medicine - Bisphosphonates Review
[7] WebMD - Red Clover Overview